Cargando…
Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862288/ https://www.ncbi.nlm.nih.gov/pubmed/35973076 http://dx.doi.org/10.2337/dc22-0921 |
| _version_ | 1784875055900000256 |
|---|---|
| author | Gérard, Alexandre O. Laurain, Audrey Favre, Guillaume Drici, Milou-Daniel Esnault, Vincent L.M. |
| author_facet | Gérard, Alexandre O. Laurain, Audrey Favre, Guillaume Drici, Milou-Daniel Esnault, Vincent L.M. |
| author_sort | Gérard, Alexandre O. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9862288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98622882023-02-03 Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? Gérard, Alexandre O. Laurain, Audrey Favre, Guillaume Drici, Milou-Daniel Esnault, Vincent L.M. Diabetes Care e-Letters – Observations American Diabetes Association 2022-10 2022-08-16 /pmc/articles/PMC9862288/ /pubmed/35973076 http://dx.doi.org/10.2337/dc22-0921 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
| spellingShingle | e-Letters – Observations Gérard, Alexandre O. Laurain, Audrey Favre, Guillaume Drici, Milou-Daniel Esnault, Vincent L.M. Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title | Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title_full | Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title_fullStr | Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title_full_unstemmed | Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title_short | Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth? |
| title_sort | activation of the tubulo-glomerular feedback by sglt2 inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: toward the end of a myth? |
| topic | e-Letters – Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862288/ https://www.ncbi.nlm.nih.gov/pubmed/35973076 http://dx.doi.org/10.2337/dc22-0921 |
| work_keys_str_mv | AT gerardalexandreo activationofthetubuloglomerularfeedbackbysglt2inhibitorsinpatientswithtype2diabetesandadvancedchronickidneydiseasetowardtheendofamyth AT laurainaudrey activationofthetubuloglomerularfeedbackbysglt2inhibitorsinpatientswithtype2diabetesandadvancedchronickidneydiseasetowardtheendofamyth AT favreguillaume activationofthetubuloglomerularfeedbackbysglt2inhibitorsinpatientswithtype2diabetesandadvancedchronickidneydiseasetowardtheendofamyth AT dricimiloudaniel activationofthetubuloglomerularfeedbackbysglt2inhibitorsinpatientswithtype2diabetesandadvancedchronickidneydiseasetowardtheendofamyth AT esnaultvincentlm activationofthetubuloglomerularfeedbackbysglt2inhibitorsinpatientswithtype2diabetesandadvancedchronickidneydiseasetowardtheendofamyth |